In this section
@inproceedings{Simmonds:2018:10.1136/thorax-2018-212555.141,
author = {Simmonds, NJ and Pabary, R and Kohlhaufl, J and Waller, MD and Alton, EA and Davies, JD},
doi = {10.1136/thorax-2018-212555.141},
pages = {A84--A85},
publisher = {BMJ PUBLISHING GROUP},
title = {THE ADDED VALUE OF NASAL POTENTIAL DIFFERENCE MEASUREMENT WHEN FIRST-LINE CYSTIC FIBROSIS (CF) INVESTIGATIONS ARE NON-DIAGNOSTIC},
url = {http://dx.doi.org/10.1136/thorax-2018-212555.141},
year = {2018}
}
TY - CPAPER
AU - Simmonds,NJ
AU - Pabary,R
AU - Kohlhaufl,J
AU - Waller,MD
AU - Alton,EA
AU - Davies,JD
DO - 10.1136/thorax-2018-212555.141
EP - 85
PB - BMJ PUBLISHING GROUP
PY - 2018///
SN - 0040-6376
SP - 84
TI - THE ADDED VALUE OF NASAL POTENTIAL DIFFERENCE MEASUREMENT WHEN FIRST-LINE CYSTIC FIBROSIS (CF) INVESTIGATIONS ARE NON-DIAGNOSTIC
UR - http://dx.doi.org/10.1136/thorax-2018-212555.141
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000471187500137&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
ER -
